Stephen Ritterbush is an accomplished inventor based in Great Falls, VA (US). He has made significant contributions to the field of medical technology, particularly in the assessment of vascular health. With a total of 4 patents to his name, Ritterbush continues to push the boundaries of innovation.

Latest Patents

One of his latest patents is a method and device for detecting and assessing reactive hyperemia using segmental plethysmography. This innovative method involves performing a first segmental cuff plethysmography to generate a baseline arterial compliance curve and/or a baseline pressure-area (P-A) curve. Following this, a second segmental cuff plethysmography is conducted to generate a hyperemic arterial compliance curve and/or a hyperemic P-A curve. The area between the baseline and hyperemic curves is calculated, which can serve as an indication of endothelial dysfunction (ED) and related diseases.

Career Highlights

Ritterbush is currently associated with Cordex Systems, Inc., where he applies his expertise in developing advanced medical devices. His work focuses on improving diagnostic methods that can lead to better patient outcomes.

Collaborations

Throughout his career, Ritterbush has collaborated with notable professionals in the field, including Michael David Whitt and Kathy Elizabeth Magliato. These collaborations have further enhanced the impact of his innovations.

Conclusion

Stephen Ritterbush exemplifies the spirit of innovation in medical technology. His contributions, particularly in the area of vascular health assessment, highlight the importance of research and development in improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.